United Therapeutics (UTHR) Change in Acquisitions & Divestments (2009 - 2026)

United Therapeutics has disclosed Change in Acquisitions & Divestments across 18 years of filings, most recently posting $1.3 billion for Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments rose 113.81% year-over-year to $1.3 billion; the TTM figure through Jun 2026 stood at $1.9 billion (down 3.39% YoY), while the FY2025 annual figure was $1.9 billion, up 21.12% from the prior year.
• Change in Acquisitions & Divestments came in at $1.3 billion for Q1 2026 at United Therapeutics, up from $596.0 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $1.3 billion in Q1 2026 to a low of $131.9 million in Q1 2022.
• Average Change in Acquisitions & Divestments over 5 years is $524.4 million, with a median of $493.2 million recorded in 2023.
• Year-over-year, Change in Acquisitions & Divestments jumped 438.06% in 2023 and sank 44.27% in 2024.
• Over 5 years, Change in Acquisitions & Divestments stood at $268.6 million in 2022, then jumped by 96.09% to $526.7 million in 2023, then retreated by 9.25% to $478.0 million in 2024, then gained by 24.69% to $596.0 million in 2025, then surged by 119.45% to $1.3 billion in 2026.
• Per Business Quant data, the three most recent Change in Acquisitions & Divestments figures were $1.3 billion in Q1 2026, $596.0 million in Q3 2025, and $653.9 million in Q2 2025.